SIDE-VIEWING RAMAN OPTICAL FIBER PROBE FOR BIOMEDICAL SPECTROSCOPY
用于生物医学光谱学的侧视拉曼光纤探头
基本信息
- 批准号:8364148
- 负责人:
- 金额:$ 2.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-06-01 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:Biomedical ResearchBreastBreast MicrocalcificationCalciumClinical ResearchCore BiopsyDepositionDevicesFiberFiber OpticsFundingGrantLasersLightMammary Gland ParenchymaMammographyMineralsNational Center for Research ResourcesNeedle biopsy procedureNeedlesPrincipal InvestigatorRaman Spectrum AnalysisResearchResearch InfrastructureResourcesSaltsScreening procedureSideSignal TransductionSourceSpectrum AnalysisTimeUnited States National Institutes of Healthclinically significantcostdesignin vivooptical fiber
项目摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
We are investigating the usage of Raman spectroscopy to guide stereotactic core needle biopsies of the breast for suspicious microcalcifications discovered at screening mammography. Microcalcifications are deposits of calcium mineral salts within breast tissue that mammographically localize the most clinically significant abnormality and are, therefore, a target for subsequent needle biopsy.
Raman spectroscopy is exquisitely sensitive to the presence of calcium-containing minerals, and thus can be used to detect and localize microcalcifications in the breast. This can be done in vivo, in real-time, in a non-destructive manner, via optical fiber probes that are compatible with existing needle biopsy devices. The side-viewing Raman fiber optic probe provides capability of utilizing the excitation light from Raman source and delivering to and collecting the light from the breast tissue while the probe inserted into needle device. The probe is designed to fit into 9 gauge needle device most commonly used during stereotactic core needle biopsies. Similar to the front-viewing Raman probe that has been successfully used in the in vivo and ex vivo clinical studies, the side-viewing probe incorporate excitation and emission filters with coatings to suppress fiber background and enable efficient extraction of the Raman signal.
这个子项目是许多利用资源的研究子项目之一
由NIH/NCRR资助的中心拨款提供。子项目的主要支持
而子项目的主要调查员可能是由其他来源提供的,
包括其它NIH来源。 列出的子项目总成本可能
代表子项目使用的中心基础设施的估计数量,
而不是由NCRR赠款提供给子项目或子项目工作人员的直接资金。
我们正在研究使用拉曼光谱引导立体定向核心针活检的乳房可疑微钙化发现筛查乳腺X线摄影。微钙化是乳腺组织内钙矿物盐的沉积,其通过乳房X线摄影定位最具临床意义的异常,因此是随后针吸活检的目标。
拉曼光谱对含钙矿物质的存在非常敏感,因此可用于检测和定位乳房中的微钙化。这可以通过与现有的针式活检装置兼容的光纤探针以非破坏性的方式在体内实时完成。侧视拉曼光纤探头提供了利用来自拉曼源的激发光并在探头插入针装置时将光传递到乳房组织并从乳房组织收集光的能力。该探头设计为适合在立体定向空心针活检过程中最常用的9号针器械。与已成功用于体内和体外临床研究的前视拉曼探针类似,侧视探针结合了具有涂层的激发和发射滤光片,以抑制光纤背景并能够有效提取拉曼信号。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NARAHARA CHARI DINGARI其他文献
NARAHARA CHARI DINGARI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NARAHARA CHARI DINGARI', 18)}}的其他基金
IN VIVO CLINICAL RAMAN SPECTROSCOPY OF BREAST CANCER
乳腺癌体内临床拉曼光谱
- 批准号:
8364140 - 财政年份:2011
- 资助金额:
$ 2.97万 - 项目类别:
EX VIVO CLINICAL RAMAN SPECTROSCOPY OF BREAST CANCER
乳腺癌离体临床拉曼光谱
- 批准号:
8364139 - 财政年份:2011
- 资助金额:
$ 2.97万 - 项目类别:
相似海外基金
Intelligent Breast Cancer DiagnOsis and MonItoring Therapeutic Response Training Network (CanDoIt)
智能乳腺癌诊断和监测治疗反应训练网络(CanDoIt)
- 批准号:
EP/Y03693X/1 - 财政年份:2024
- 资助金额:
$ 2.97万 - 项目类别:
Research Grant
From single-cell transcriptomic to single-cell fluxomic: characterising metabolic dysregulations for breast cancer subtype classification
从单细胞转录组到单细胞通量组:表征乳腺癌亚型分类的代谢失调
- 批准号:
EP/Y001613/1 - 财政年份:2024
- 资助金额:
$ 2.97万 - 项目类别:
Research Grant
Preclinical validation of synthetic biomolecules to treat Breast Cancer from AI-enabled discovery of novel lncRNA therapeutic targets.
通过人工智能发现新型 lncRNA 治疗靶点,对合成生物分子治疗乳腺癌进行临床前验证。
- 批准号:
10110204 - 财政年份:2024
- 资助金额:
$ 2.97万 - 项目类别:
Launchpad
Quad negative breast cancerに対する新たなプレシジョン・メディシン治療戦略
四阴性乳腺癌精准医学治疗新策略
- 批准号:
24K11748 - 财政年份:2024
- 资助金额:
$ 2.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ESR1 mutation profiling identifies potential drivers of metastatic breast cancer
ESR1 突变分析确定了转移性乳腺癌的潜在驱动因素
- 批准号:
MR/X018199/1 - 财政年份:2024
- 资助金额:
$ 2.97万 - 项目类别:
Research Grant
Spatial-BrTME: Multicellular spatial dynamics of immunotherapy response in breast cancer
Spatial-BrTME:乳腺癌免疫治疗反应的多细胞空间动力学
- 批准号:
EP/Y014995/1 - 财政年份:2024
- 资助金额:
$ 2.97万 - 项目类别:
Research Grant
Enhancements to design and testing of Body Aspect's breast volume measurement software
Body Aspect 乳房体积测量软件的设计和测试得到增强
- 批准号:
10074432 - 财政年份:2023
- 资助金额:
$ 2.97万 - 项目类别:
Collaborative R&D
Decoding the impact of single cell mutational processes in triple negative breast cancer and high grade serous ovarian cancer
解读单细胞突变过程对三阴性乳腺癌和高级别浆液性卵巢癌的影响
- 批准号:
477662 - 财政年份:2023
- 资助金额:
$ 2.97万 - 项目类别:
Operating Grants
225Ac-labeled anti-nectin-4 radioimmunoconjugate with/without immune checkpoint blockage in triple negative breast cancer.
225Ac 标记的抗 nectin-4 放射免疫缀合物,有/没有免疫检查点阻断治疗三阴性乳腺癌。
- 批准号:
488261 - 财政年份:2023
- 资助金额:
$ 2.97万 - 项目类别:
Operating Grants
Identifying the molecular and environmental factors involved in promoting escape from breast cancer dormancy.
确定参与促进乳腺癌休眠逃逸的分子和环境因素。
- 批准号:
488246 - 财政年份:2023
- 资助金额:
$ 2.97万 - 项目类别:
Operating Grants














{{item.name}}会员




